Aeterna Zentaris Appoints President and CEO

Aeterna Zentaris Inc (NASDAQ:AEZS, TSX:AEZ) announced the appointment of David A. Dodd as the company’s President and Chief Executive Officer.

As quoted in the press release:

With the appointment of David, we are taking an important first step in transforming Aeterna Zentaris from a company focused on R&D to a company focused on commercializing the promising compounds in our pipeline,” said Juergen Ernst, Chairman of the Board of Directors. “David’s reputation in the industry as a ‘transformation specialist’ is well deserved, with a record of successful and dramatic transformations of multiple pharmaceutical and biotechnology enterprises.  David is a strong, focused leader with the ability to motivate employees, and significantly enhance shareholder value.  We are delighted that he is joining our management team, and we look forward to his leadership and stewardship of Aeterna Zentaris.

Click here to read the full Aeterna Zentaris Inc (NASDAQ:AEZS, TSX:AEZ) press release.